Lotus Bio Company Top Management

LBTD Stock  USD 0.01  0.00  0.00%   
Lotus Bio employs about 4 people. The company is managed by 2 executives with a total tenure of roughly 6 years, averaging almost 3.0 years of service per executive, having 2.0 employees per reported executive. Evaluation of Lotus Bio's management performance can provide insight into the firm performance.
Zoltan Nagy  CEO
President CEO, Director
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lotus Bio Technology Development. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Lotus Bio Management Team Effectiveness

The company has return on total asset (ROA) of (4.213) % which means that it has lost $4.213 on every $100 spent on assets. This is way below average. Lotus Bio's management efficiency ratios could be used to measure how well Lotus Bio manages its routine affairs as well as how well it operates its assets and liabilities.

Lotus Bio Workforce Comparison

Lotus Bio Technology Development is currently regarded as number one stock in number of employees category among its peers. The total workforce of Consumer Discretionary industry is now estimated at about 42,495. Lotus Bio adds roughly 4.0 in number of employees claiming only tiny portion of stocks in Consumer Discretionary industry.

Lotus Bio Technology Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Lotus Bio Technology Price Series Summation is a cross summation of Lotus Bio price series and its benchmark/peer.

Lotus Bio Notable Stakeholders

A Lotus Bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Lotus Bio often face trade-offs trying to please all of them. Lotus Bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Lotus Bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Zoltan NagyPresident CEO, DirectorProfile
Hoyt ChristopherChief OfficerProfile

About Lotus Bio Management Performance

The success or failure of an entity such as Lotus Bio Technology often depends on how effective the management is. Lotus Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Lotus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Lotus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Lotus Bio-Technology Development Corp., a bio-technology development company, focuses on refining organic materials, and production of natural consumer related products in China. Lotus Bio-Technology Development Corp. was founded in 2011 and is based in Cave Creek, Arizona. Lotus Bio-Technology is traded on OTC Exchange in the United States.
Please note, the presentation of Lotus Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Lotus Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Lotus Bio's management manipulating its earnings.

Lotus Bio Workforce Analysis

Traditionally, organizations such as Lotus Bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Lotus Bio within its industry.

Lotus Bio Manpower Efficiency

Return on Lotus Bio Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee4.9K
Net Loss Per Executive9.8K

Complementary Tools for Lotus Pink Sheet analysis

When running Lotus Bio's price analysis, check to measure Lotus Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Bio is operating at the current time. Most of Lotus Bio's value examination focuses on studying past and present price action to predict the probability of Lotus Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Bio's price. Additionally, you may evaluate how the addition of Lotus Bio to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency